The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer

Cancer Causes and Control

Volumn 25, Issue 11, 2014, Pages 1531-1541

  Divella, Rosa ^a   Daniele, Antonella ^a   Abbate, Ines ^a   Bellizzi, Antonia ^a   Savino, Eufemia ^a   Simone, Giovanni ^a   Giannone, Grazia ^a   Giuliani, Francesco ^a   Fazio, Vito ^a   Gadaleta Caldarola, Gennaro ^a   Gadaleta, Cosimo Damiano ^a   Lolli, Ivan ^b   Sabbà, Carlo ^b   Mazzocca, Antonio ^b,c  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Cell clusters; CTCs; CXCL1; Metastasis; PAI 1; TGF beta; VEGF

Indexed keywords

CXCL1 CHEMOKINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; CXCL1 PROTEIN, HUMAN; CYTOKINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL POPULATION; CHEMOSENSITIVITY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOMAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OVERALL SURVIVAL; PHENOTYPE; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; BLOOD; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; ITALY; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHEMOKINE CXCL1; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PHENOTYPE; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84911975412     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0457-4     Document Type: Article

References (39)

1. Bardhan K, Liu K (2013) Epigenetics and colorectal cancer pathogenesis. Cancers 5(2):676–713
2. Marudanayagam R, Ramkumar K, Shanmugam V, Langman G, Rajesh P, Coldham C, Bramhall SR, Mayer D, Buckels J, Mirza DF (2009) Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma. HPB (Oxford) 11(8):671–676
3. Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, Taylor BR, Langer B, Gallinger S, Wei AC (2006) Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202(3):468–475
4. Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, D’Angelica M, Fong Y, Blumgart LH, DeMatteo RP (2007) Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 205(2):231–238
5. Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet 1:571–573
6. Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
7. Balzer EM, Konstantopoulos K (2012) Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers. Wiley Interdiscip Rev Syst Biol Med 4(2):171–181
8. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112(1):3–25
9. Gassmann P, Haier J (2008) The tumor cell-host organ interface in the early onset of metastatic organ colonization. Clin Exp Metastasis 25(2):171–181
10. Gassmann P, Enns A, Haier J (2004) Role of tumor cell adhesion and migration in organ specific metastasis formation. Onkologie 27(6):577–582
11. Richmond A (2010) Chemokine modulation of the tumor microenvironment. Pigment Cell Melanoma Res 23(3):312–313
12. Spano D, Heckc C, De Antonellis P, Christofori G, Zollo M (2012) Molecular networks that regulate cancer metastasis. Semi Cancer Biol 22:234–249
13. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550
14. Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, Giannelli G (2010) Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 51(2):523–534
15. Divella R, Daniele A, Gadaleta C, Tufaro A, Venneri MT, Paradiso A, Quaranta M (2012) Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis. Anticancer Res 32(1):141–145
16. Ogata H, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, Imura J, Ito Y, Fujita M, Tsubaki M, Kato H, Fujimori T, Fukui H (2010) GROα promotes invasion of colorectal cancer cells. Oncol Rep 24(6):1479–1486
17. Imamura T, Hikita A, Inoue Y (2012) The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 19(2):118–124
18. Divella R, Lacalamita R, Tommasi S, Coviello M, Daniele A, Garrisi VM, Abbate I, Simone G, Gadaleta C, Paradiso A, Quaranta M (2008) PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis. Anticancer Res 28(1A):223–228
19. Halamkova J, Kiss I, Pavlovsky Z, Tomasek J, Jarkovsky J, Cech Z, Tucek S, Hanakova L, Moulis M, Zavrelova J, Man M, Benda P, Robek O, Kala Z, Penka M (2011) Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients. Neoplasma 58(5):377–385
20. Xu B, Shen F, Cao J, Jia L (2013) Angiogenesis in liver metastasis of colorectal carcinoma. Front Biosci (Landmark Ed) 18:1435–1443
21. Liu W, Xu J, Wang M, Wang Q, Bi Y, Han M (2011) Tumor derived vascular endothelial growth factor (VEGF-a) facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway. Int J Oncol 39:1213–1220
22. Bellizzi A, Sebastian S, Ceglia P, Centonze M, Divella R, Manzillo EF, Azzariti A, Silvestris N, Montemurro S, Caliandro C, De Luca R, Cicero G, Rizzo S, Russo A, Quaranta M, Simone G, Paradiso A (2013) Co-expression of CD133 (+)/CD44 (+) in human colon cancer and liver metastasis. J Cell Physiol 228(2):408–415
23. Schluter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, Holzen J, Haier J (2006) Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 169(3):1064–1073
24. Sleemana JP, Christofori G, Fodded R, Collarde JG, Berx G, Decraeneh C, Rüegg C (2012) Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 22:174–186
25. Lorusso G, Rüegg C (2012) New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 22:226–233
26. Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G (2013) Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol 23:522–532
27. Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A (2013) Circulating levels of transforming growth factor-beta (TGF-beta) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Anticancer Res 33(4):1491–1497
28. Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16(3):133–144
29. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massagué J (2012) A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150(1):165–178
30. Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30(5):525–532
31. Kochetkova M, Kumar S, McColl SR (2009) Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ 16(5):664–673
32. Muñoz NM, Baek JY, Grady WM (2008) TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines. Growth Factors 26(5):254–262
33. Mazzocca A, Fransvea E, Lavezzari G, Antonaci S, Giannelli G (2009) Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation. Hepatology 50(4):1140–1151
34. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374
35. Colussi D, Brandi G, Bazzoli F, Ricciardiello L (2013) Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 14(8):16365–16385
36. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367(17):1596–1606
37. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61(6):847–854
38. Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012) Colorectal cancer: a tale of two sides or a continuum? Gut 6:794–797
39. Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD (2013) Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol 26(6):825–834